Chinese medicine for treating hyperosteogeny of cervical vertebra and lumbar vertebrae
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology for bone hyperplasia and cervical and lumbar vertebrae, which is applied in bone diseases, drug combinations, pharmaceutical formulations, etc., and can solve the problems of high recurrence probability, low cure rate, and long time.
Inactive Publication Date: 2011-09-21
张彦
View PDF0 Cites 7 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
[0003] At present, Western medicine mainly adopts surgery as the main treatment method for bone hyperplasia, supplemented by drug treatment, but the operation will bring pain to the patient, and the patient needs a long period of bed rest after the operation to recover, and the possibility of recurrence is high; Chinese medicine also has Some therapeutic drugs and methods, but the time is longer and the cure rate is low
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0008] Get 30 parts of Astragalus, 12 parts of Dodder, 12 parts of Paeoniae Alba, 12 parts of Caulis Spatholobus, 12 parts of Pueraria Radix, 12 parts of Angelica, 12 parts of Lycium barbarum, 12 parts of Chuan Duan, 10 parts of Dilong, 15 parts of Duhuo, 10 parts of Eucommia ulmoides, 10 parts of Clematis, 9 parts of licorice, 12 parts of Morinda officinalis, 30 parts of pituitary bark, 12 parts of drynaria, 12 parts of dog ridge, 15 parts of psoralen, and 15 parts of Achyranthes bidentata. Decoction in water, one dose a day, twice a day.
Embodiment 2
[0010] Take 30 parts by weight, 10 parts of dodder, 10 parts of white peony root, 10 parts of Caulis Spatholobus, 10 parts of kudzu root, 10 parts of angelica, 10 parts of medlar, 10 parts of chuanduan, 10 parts of earthworm, 15 parts of duhuo, Eucommia 10 parts, 10 parts of clematis, 10 parts of licorice, 10 parts of Morinda officinalis, 30 parts of pituitary bark, 10 parts of drynaria, 10 parts of dog spine, 15 parts of psoralen, and 15 parts of Achyranthes bidentata. Decoction in water, one dose a day, twice a day.
Embodiment 3
[0012] Get 30 parts of Astragalus, 14 parts of Dodder, 14 parts of Paeoniae Alba, 14 parts of Caulis Spatholobus, 10 parts of Pueraria Radix, 10 parts of Angelica, 14 parts of Lycium barbarum, 8 parts of Chuan Duan, 8 parts of Dilong, 10 parts of Duhuo, 8 parts of Eucommia ulmoides, 10 parts of Clematis, 8 parts of licorice, 8 parts of Morinda officinalis, 20 parts of pituitary bark, 12 parts of drynaria, 12 parts of dog ridge, 15 parts of psoralen, and 15 parts of Achyranthes bidentata. Decoction in water, one dose a day, twice a day.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a Chinese medicine for treating hyperosteogeny of cervical vertebra and lumbar vertebrae. The medicine comprises ingredients of, by weight: radix astragali 20 to 40 parts, semen cuscutae 8 to 16 parts, white peony root 8 to 16 parts, spatholobus stem 8 to 16 parts, kudzu vine root 8 to 16 parts, Chinese angelica 8 to 16 parts, wolfberry 8 to 16 parts, Sichuan radix dipsaci 8 to 16 parts, lumbricus 8 to 16 parts, levisticum 10 to 20 parts, eucommia 8 to 16 parts, clematis root 8 to 16 parts, licorice 8 to 16 parts, morinda officinalis 8 to 16 parts, seatung bark 20 to 40 parts, rhizoma drynariae 8 to 16 parts, cibotium rhizome 8 to 16 parts, psoralea corylifolia 10 to 20 parts, and achyranthcs bidentata blume 10 to 20 parts. The medicine provided by the present invention can be used for treating hyperosteogeny caused by vital energy stagnancy, blood stasis, meridian impotency, and vital energy and blood insufficiency. The medicine has medical effects of kidney tonifying, blood nourishing, collaterals activating, pain relieving, tendons and bones strengthening, swelling eliminating, and binds dissipating. The medicine is an oral Chinese medicine for treating hyperosteogeny of cervical vertebra and lumbar vertebrae.
Description
technical field [0001] The invention belongs to the field of traditional Chinese medicines, and specifically refers to a traditional Chinese medicine for treating cervical and lumbar hyperosteogeny. Background technique [0002] Osteoarthritis is also known as hyperplastic osteoarthritis, osteoarthritis, degenerative joint disease, senile arthritis, and hypertrophic arthritis. Bone spurs are formed on the edge, synovial hypertrophy and other changes, resulting in bone destruction, causing secondary bone hyperplasia, resulting in joint deformation. When subjected to abnormal loads, it causes joint pain and limited mobility. Divided into two kinds of primary and secondary. Pathologically, irregular cartilage lesions, subchondral sclerosis, cysts, marginal osteophytes, increased metaphyseal blood flow, and varying degrees of synovitis were found in the weight-bearing areas. [0003] At present, Western medicine mainly adopts surgery as the main treatment method for bone hyper...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more